TITAN PHARMACEUTICALS INC DE's ticker is TTNP and the CUSIP is 888314606. A total of 24 filers reported holding TITAN PHARMACEUTICALS INC DE in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $38,892 | -26.6% | 82,051 | 0.0% | 0.00% | – |
Q2 2023 | $53,021 | -22.1% | 82,051 | 0.0% | 0.00% | – |
Q1 2023 | $68,102 | +6.0% | 82,051 | 0.0% | 0.00% | – |
Q4 2022 | $64,254 | -27.0% | 82,051 | +0.2% | 0.00% | – |
Q3 2022 | $88,000 | +109.5% | 81,924 | +9.4% | 0.00% | – |
Q2 2022 | $42,000 | -78.7% | 74,895 | -63.7% | 0.00% | – |
Q1 2022 | $197,000 | -6.2% | 206,428 | 0.0% | 0.00% | – |
Q4 2021 | $210,000 | -45.6% | 206,428 | -0.1% | 0.00% | – |
Q3 2021 | $386,000 | -27.3% | 206,695 | +1.2% | 0.00% | – |
Q2 2021 | $531,000 | +144.7% | 204,324 | +180.7% | 0.00% | – |
Q1 2021 | $217,000 | +16.7% | 72,791 | +28.4% | 0.00% | – |
Q4 2020 | $186,000 | – | 56,691 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GSA CAPITAL PARTNERS LLP | 39,820 | $119,000 | 0.02% |
Westside Investment Management, Inc. | 8 | $0 | 0.00% |
American Portfolios Advisors | 23 | $69 | 0.00% |
JPMORGAN CHASE & CO | 78 | $0 | 0.00% |
ROYAL BANK OF CANADA | 17 | $0 | 0.00% |
VANGUARD GROUP INC | 72,791 | $217,000 | 0.00% |
UBS Group AG | 23,459 | $70,000 | 0.00% |
Sowell Financial Services LLC | 19 | $0 | 0.00% |
OSAIC HOLDINGS, INC. | 15 | $0 | 0.00% |
BANK OF AMERICA CORP /DE/ | 138 | $0 | 0.00% |